CClinicalTrials.gg
TerminatedNCT02547298Updated Jan 26, 2022

Interstitial Cystitis (IC)-Like Findings With Hydrodistension

An observational study in Interstitial Cystitis, sponsored by St. Louis University. Terminated at 1 site in United States. Open to female participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2022-01-26.

Sponsored by St. Louis University · Observational

Why this study was terminated
Previous PI left, staffing changes especially in setting of COVID pandemic meant we no longer wanted to proceed with further recruitment. There were no adverse events or concerns leading to the termination of the study. Simply logistical concerns
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
734
Ages
18 Years to 90 Years
Sex
Female
01

Study summary

Patients who are already scheduled to have a gynecologic, urologic or uro-gynecologic procedure involving cystoscopy (a lighted scope is used to look inside the bladder) under anesthesia will be approached to participate in the study. Once prospective study subjects are consented, they will be requested to complete the study questionnaires.

At the time of the procedure, during the cystoscopy, patients will undergo hydrodistension (stretching the bladder with fluid). Photographic images of the bladder will be collected, to be later analyzed by examiners. Patients who have positive findings for interstitial cystitis during cystoscopy with hydrodistension, will be notified of the findings after the procedure.

They will be asked to fill out an additional, previously completed questionnaire at the time of a follow-up visit, during a phone interview or responding to the questionnaire via a secure web site. These patients will be treated for interstitial cystitis by their primary providers as clinically indicated.

Read the detailed description

Patients who are already scheduled to have a gynecologic, urologic or uro-gynecologic procedure involving cystoscopy will be approached to participate in the study. They will be approached either at the time of an office visit or on the day of the scheduled procedure in the preoperative area.

Study-Related Once consented, they will be requested to fill out the study questionnaires. IC Problem Index/IC symptom Index, Pelvic Pain and Urgency/Frequency Patient Symptom Scale(PUF), IBS (Irritable Bowel Syndrome) questionnaire, Functional Esophageal Disorder Questionnaire, and Painful Bladder questionnaire. Completion of these questionnaires should take approximately 15 minutes.

All patients will undergo cystoscopy with hydrodistension as part of the study protocol. Cystoscopy with hydrodistension is used as a diagnostics/evaluative test.

Cystoscopy-Standard of care The bladder will be be emptied prior to cystoscopy. Cystoscopy will be performed with a 5 mm 30o or 70o cystoscope. The angle of view through the scope (or what the physician sees) is described as 30 degrees or 70 degrees. Sterile saline or water will be infused under direct visualization. Fluid bag will be held at 80 cm above the patient. After 200 cc's of filling the infusion will be stopped. This is the standard procedure for cystoscopy. A resurvey of the bladder will be performed. A minimum of two pictures will be taken - one of the back wall and one of the dome of the bladder. Any abnormal findings will be recorded as well.

Hydrodistension- standard of care or study related. The bladder will be filled by gravity (no pressure) the fluid bag is held 80-100cm above the bed level and the bladder is filled by gravity. Fluid will stop when the bladder reaches capacity or the physician will stop the flow when 700cc is reached. Once the bladder is filled, it is then partially emptied. This procedure should take no more than 60 seconds. The bladder is left partially filled so the physician can take a final look (resurvey) at the bladder before the procedure is completed and the scope withdrawn. This is the standard procedure for hydrodistension. At least five pictures will be taken: trigon, left and right bladder wall, posterior wall of the bladder, and dome of the bladder. A short video clip (approximately 10-15 seconds long) will be taken as well for documentation. Again, any abnormal findings will be documented.

Image review-study related Cystoscopic images will be de-identified and pooled. Batches of 25 sets of images will be evaluated by a panel of urogynecologists. Each reviewer will evaluate each set of images, ranking them as: positive, equivocal or negative for interstitial cystitis findings. A minimum of 10 glomerulations per quadrant in 3 out of 4 quadrants, or any Hunner ulcers will be required for positive diagnosis. Glomerulations will be graded by distribution and number. Additional findings will be recorded: trabeculations, metaplasia, masses, stones, etc. In cases of equivocal findings, the panel can review video clip that may contain additional visual information.

Study related Patients who have positive findings for interstitial cystitis during cystoscopy with hydrodistension, will be notified of the findings after the procedure. At their 4 week and 6 month followup visits these patients will be asked to fill out the IC Problem Index/IC symptom Index questionnaire, this will be compared to the same questionnaire the patient filled out pre op. If the patient is unable to come to the office they may receive a phone call to complete the questionnaire or if they have access to e-mail they may be able to complete the questionnaire on a secure web base site (Red Cap). The follow up questionnaire will not be completed by those who are not diagnosed with interstitial cystitis and their participation in this study will end after the procedure, and they will be referred back to their primary or referring physician for follow up.

Study related The patient's medical record will also be reviewed for history and demographics.

Standard of care Patients with IC will be treated by their primary providers as clinically indicated.

02

Conditions studied

  • Interstitial Cystitis
03

In context

Cystitis

235 studies on the registry are indexed under Cystitis; 22 are open to participants now.

This study's enrollment of 734 is above the median of 86 across 50 observational studies indexed under Cystitis.

Browse Cystitis studies →

Lead sponsor

St. Louis University is the lead sponsor of 152 studies on the registry; 17 are open to participants now.

Of its 19 completed or terminated interventional studies of FDA-regulated products, 15 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All women scheduled to undergo cystoscopy or cystoscopy with hydrodistension in an academic institution, within the benign gynecologic division with eligibility criteria as above.

Inclusion criteria

  1. Female
  2. Patients must be at least 18 years of age.
  3. Patients must have been previously scheduled for a surgical procedure that includes cystoscopy under anesthesia or cystoscopy with hydrodistension under anesthesia.
  4. Patients must be able to provide written informed consent.

Exclusion criteria

Exclusion Criteria:

  1. pregnancy
  2. planned cystotomy
  3. incidental cystotomy during surgery - patient not eligible for hydrodistention
  4. patient's age > 90
  5. history of pelvic radiation 6, Previous or newly diagnosed bladder tumor
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
734 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • All participants

    All participants will be filling out questionnaires and undergoing cystoscopy with hydrodistension for evaluative reasons

06

What researchers measure

Primary outcomes

  1. Correlation between severity of urinary symptoms and IC-like findings on cystoscopy with hydrodistension.

    Change From Baseline in Pain on the 11 point Short Pain Scale (SPS-11).

    Time frame: up to 5 years

Secondary outcomes

  1. The association of GI symptoms with IC-like findings on cystoscopy with hydrodistension

    Correlation between questionnaires responses and cystoscopic findings

    Time frame: up to 5 years

  2. The correlation between O'Leary-Sant score and cystoscopic findings

    correlation between O'Leary-Sant score and cystoscopic findings

    Time frame: up to 5 years

  3. The correlation between PUF score and cystoscopic findings

    Correlation between PUF score and cystoscopic findings

    Time frame: up to 5 years

  4. The association between cystoscopic and previous urologic or gynecologic surgeries

    Correlation between cystoscopic and previous urologic or gynecologic surgeries

    Time frame: up to 5 years

  5. The number of patients with interstitial cystitis who's symptoms improve after cystoscopy with hydrodistension

    To evaluate the number of patients with interstitial cystitis who's symptoms improve after cystoscopy with hydrodistension based on questionnaire responses

    Time frame: up to 5 years

  6. Cystoscopic findings in this patient population

    To evaluate other cystoscopic findings in this patient population based on review of reports and photos

    Time frame: up to 5 years

  7. The safety and complications after cystoscopy with hydrodistension

    Number of Participants With Treatment-Related Adverse Events as Assessed by CTCAE v4.0

    Time frame: up to 5 years

07

Study locations

1 site
  • St. Mary's Health Center
    Saint Louis, Missouri 63117, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 26, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02547298
Lead sponsor
St. Louis University
Responsible party
Ioana Marcu, MD (MD, St. Louis University) — Principal investigator
First posted
Sep 11, 2015
Start date
Jun 2015
Primary completion
Jan 18, 2018
Completion
Jan 18, 2018
Last update
Jan 26, 2022

Study contacts

Ioana Marcu, MD
principal investigator · St. Louis University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion